Filter By Industry
Filter By Tag

Newsroom

Varian Biopharmaceuticals, Inc. Press releases

1 - 1 of 1 Press Release

Nov 15, 2021
Varian Biopharmaceuticals is Developing a Proprietary atypical Protein Kinase C iota Inhibitor in Multiple Formulations for A Broad Range of Tumor Types


Varian Biopharmaceuticals, Inc. RSS Feed